Cargando…
Congenital myasthenic syndromes due to mutations in ALG2 and ALG14
Congenital myasthenic syndromes are a heterogeneous group of inherited disorders that arise from impaired signal transmission at the neuromuscular synapse. They are characterized by fatigable muscle weakness. We performed linkage analysis, whole-exome and whole-genome sequencing to determine the und...
Autores principales: | Cossins, Judith, Belaya, Katsiaryna, Hicks, Debbie, Salih, Mustafa A., Finlayson, Sarah, Carboni, Nicola, Liu, Wei Wei, Maxwell, Susan, Zoltowska, Katarzyna, Farsani, Golara Torabi, Laval, Steven, Seidhamed, Mohammed Zain, Donnelly, Peter, Bentley, David, McGowan, Simon J., Müller, Juliane, Palace, Jacqueline, Lochmüller, Hanns, Beeson, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580273/ https://www.ncbi.nlm.nih.gov/pubmed/23404334 http://dx.doi.org/10.1093/brain/awt010 |
Ejemplares similares
-
Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies
por: Belaya, Katsiaryna, et al.
Publicado: (2015) -
Structural Analysis of the Effect of Asn107Ser Mutation on Alg13 Activity and Alg13-Alg14 Complex Formation and Expanding the Phenotypic Variability of ALG13-CDG
por: Mitusińska, Karolina, et al.
Publicado: (2022) -
The Argonaute Proteins ALG-1 and ALG-2 Are Linked to Stress Resistance and Proteostasis
por: Finger, Fabian, et al.
Publicado: (2021) -
Chemo-enzymatic synthesis of lipid-linked GlcNAc(2)Man(5) oligosaccharides using recombinant Alg1, Alg2 and Alg11 proteins
por: Ramírez, Ana S, et al.
Publicado: (2017) -
Immunomodulation Therapy for Severe Aplastic Anemia: —ALG Versus ALG Plus Cyclosporin A—
por: Park, Chong Won, et al.
Publicado: (1989)